42 CFR Part 2-Compliant Software Development: What SUD Treatment Software Actually Has to Do
- 5h
- 7 min read
Most developers who build healthcare software know HIPAA. Far fewer know that substance use disorder records carry a second, stricter layer of federal protection — 42 CFR Part 2 — that changes how the software has to handle consent, data segregation, and disclosure. And the stakes just rose: enforcement of the modernized 2024 Part 2 rule began in February 2026. For behavioral health and addiction treatment providers, building or buying software that touches SUD records without engineering for Part 2 is a compliance exposure waiting to surface. This guide covers what custom software development for SUD treatment actually has to do to be Part 2-compliant.
42 CFR Part 2-compliant software development is the practice of building applications that handle substance use disorder (SUD) treatment records with the specific protections Part 2 requires — granular consent management, segregation of Part 2 data, re-disclosure prohibition notices, and an accounting of disclosures — beyond the HIPAA safeguards that govern general PHI. It applies to any system a Part 2 program uses to create, store, or share SUD records: EHRs, intake tools, billing, HIEs, and the integrations between them.
Why is Part 2 not just HIPAA?
Because Part 2 was written to protect a category of patient that stigma and the law treat differently, and it imposes requirements HIPAA doesn't. Here's where the two diverge — and what each difference means for the software.
Requirement | HIPAA | 42 CFR Part 2 (SUD) | Software implication |
Disclosure for treatment/payment/operations | Generally allowed without separate consent | Requires patient consent (single consent now allowed post-2024) | Consent must be modeled and enforced, not assumed |
Consent specificity | Broad authorizations | Scope must be tracked; counseling notes need separate consent | Granular, typed consent records |
Re-disclosure | Not specifically restricted | Recipients must be notified data can't be re-disclosed | Attach a prohibition notice on every disclosure |
Accounting of disclosures | Limited | Stricter expectation of who got what | Log every disclosure with consent linkage |
Data segregation | Not required | Part 2 data often must be identifiable/segregable | Tag and segregate SUD records in the data model |
The pattern is clear: Part 2 turns consent and disclosure from background assumptions into first-class features the software has to model. A system that's perfectly HIPAA-compliant can still violate Part 2, because Part 2 asks for things HIPAA never does.
What did the 2024 Final Rule change — and why does it matter now?
Because the rules just changed and enforcement just began, making this the moment SUD software has to get it right. On February 16, 2024, SAMHSA released a final rule modernizing Part 2; it took effect April 16, 2024, and enforcement of the updated requirements began February 16, 2026 (HHS). The changes are consequential for software:
A single consent can now cover all future uses and disclosures for treatment, payment, and operations — a major simplification, but the software has to support and track that consent model.
Each disclosure made with consent must include a copy of the consent or a clear explanation of its scope — a documentation requirement the system has to generate.
SUD counseling notes require a separate patient consent — the data model has to distinguish counseling notes and gate them independently.
The 2024 rule aligned Part 2 more closely with HIPAA in places, but it did not make Part 2 go away — it modernized it and put teeth behind it. Software built before 2024, or built for HIPAA without Part 2 in mind, may now be out of step with rules that are actively enforced. That's why "we're HIPAA-compliant" is no longer a sufficient answer for any system touching SUD records.
What does Part 2 compliance require in the software?
The regulation translates into a specific data lifecycle the software has to enforce — consent at the gate, a prohibition notice on the way out, and a log of everything.
Every box is a real engineering requirement. The data model has to tag Part 2 records so they're identifiable and segregable. Consent has to be captured with its scope and type, counseling notes tracked separately. At disclosure, the system has to check consent, block what isn't covered, attach the re-disclosure prohibition notice, and write the disclosure to an accounting log linked to the consent that authorized it. None of this is exotic, but all of it must be deliberate — and none of it is delivered by a generic HIPAA-compliant build.
The hard parts: segregation, consent, re-disclosure, accounting
Four problems make Part 2 software genuinely harder than general healthcare software, and they're where the engineering effort concentrates:
Data segregation. Part 2 data often has to be identifiable and separable from general PHI, so the system can apply Part 2 rules to it specifically. That's a data-model decision made early or paid for later.
Consent management. Typed, scoped, revocable consent — including the separate counseling-notes consent — modeled as structured data the system can reason about, not a scanned form.
Re-disclosure control. Every disclosure has to carry the prohibition notice, and ideally the system tracks downstream so the chain stays compliant.
Accounting of disclosures. A complete, queryable log of who received what SUD data, under which consent, when — the record you produce if a patient or regulator asks.
This is the same compliance-by-design discipline we bring to any regulated build — engineering the rules into the data model and the flows rather than bolting them on. It's also why Part 2 software is a specialized job: a systems integration and development effort that has to respect a regulation most general developers have never read. We've written about the sector's deeper data realities in our piece on why behavioral healthcare has an EHR problem that isn't the one you'd expect.
Build, buy, or integrate?
Most SUD programs should start with an EHR or platform built for addiction treatment — the good ones already model Part 2 consent and segregation, and if one fits, use it. The custom or integration case appears, as always, when the packaged tools don't cover your reality:
You're integrating Part 2 data between systems — an EHR, billing, an HIE, a state registry — where the consent and re-disclosure rules have to be enforced across the connection, not just inside one app.
You're building a custom SUD tool — an intake flow, a care-coordination app, a measurement-based-care dashboard — that touches SUD records and therefore inherits Part 2.
Your EHR predates the 2024 rule or handles Part 2 weakly, and you need to extend or wrap it to meet the now-enforced requirements.
You operate across the SUD/general-care boundary — an integrated setting where Part 2 data mixes with general PHI and segregation must be engineered.
If a packaged Part 2-aware tool fits, use it; building would be waste. If you're integrating or extending around SUD data, that's custom work where Part 2 has to be a design input, and the same custom-versus-off-the-shelf judgment applies — leaning custom because the regulation is this specific.
Building or integrating software that touches SUD records? Book a free consultation and we'll review your architecture against Part 2 — consent, segregation, re-disclosure, accounting — and the now-enforced 2024 rule, and tell you where the real gaps are before a regulator does. No obligation.
A worked example: the integration that Part 2 broke
Take an addiction treatment provider connecting its SUD EHR to a regional HIE so that other treating providers can see a patient's records. Straightforward under HIPAA — but the project nearly shipped a Part 2 violation. The naive integration would have pushed SUD records to the HIE the way it pushes general medical data: no consent check, no re-disclosure notice, no disclosure log. Under Part 2, that's a breach, and after February 2026 it's an enforced one.
The compliant build is different in kind. SUD records are tagged as Part 2 in the EHR; the integration checks, for each record, whether the patient's consent covers disclosure to the HIE; records without consent are blocked, not sent; every disclosed record carries the re-disclosure prohibition notice; and each disclosure is logged to an accounting tied to the authorizing consent. The HIE connection still works — it just works lawfully, with Part 2 enforced in the integration logic rather than assumed away. That's the difference a Part 2-literate build makes: the same integration, engineered so the regulation is impossible to violate by accident. It's the approach we take to every behavioral health build, where the rule is a design input from line one.
What does it cost, and how should you start?
Start by inventorying where SUD records live and move in your systems — because that map is the Part 2 risk surface and the spec for any compliance work. If your EHR handles Part 2 natively and you're not integrating beyond it, you may need little. If you're connecting SUD data across systems, building a custom tool that touches it, or running on software that predates the 2024 rule, a Part 2-compliant build or integration is a bounded but real project, sized by how much consent, segregation, and disclosure logic has to be engineered. The honest sequence is: map where SUD data flows, check whether your current tools enforce Part 2 there, and build or integrate the compliance where they don't — which, with enforcement now active, is worth doing sooner rather than after an audit. We scope exactly that in a no-risk discovery.
The bottom line
42 CFR Part 2-compliant software development is what separates a system that merely meets HIPAA from one that lawfully handles substance use disorder records — modeling granular consent, segregating Part 2 data, attaching re-disclosure prohibition notices, and logging an accounting of disclosures, all of which Part 2 requires and HIPAA doesn't. With the 2024 rule now enforced as of February 2026, software that touches SUD records and was built for HIPAA alone may be out of compliance. Use an addiction-treatment platform that models Part 2 if one fits; build or integrate custom when you're connecting or extending around SUD data. Either way, Part 2 has to be engineered in, not assumed. If your systems touch SUD records, mapping where Part 2 applies is worth doing before enforcement finds the gap for you.
By the CodeStringers Team — Zoho Experts & Custom Software. CodeStringers is a custom software engineering firm that builds and integrates secure, compliance-sensitive systems for healthcare and behavioral health providers, writing from work we've actually shipped. [Book a free consultation.](/how-we-work/no-risk-discovery)
Comments